Megagen Implant India Profile
Key Indicators
- Authorised Capital ₹ 9.64 Cr
as on 29-12-2024
- Paid Up Capital ₹ 9.64 Cr
as on 29-12-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 48.59%
(FY 2023)
- Profit -2653.27%
(FY 2023)
- Ebitda -3485.33%
(FY 2023)
- Net Worth 198.70%
(FY 2023)
- Total Assets 1009.99%
(FY 2023)
About Megagen Implant India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.64 Cr and a paid-up capital of Rs 9.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yeo Lee, Kwangbum Park, Param Tripathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U52599MH2021FTC425988
- Company No.
094311
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
08 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Megagen Implant India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yeo Lee  | Director | 23-Oct-2023 | Current |
| Kwangbum Park | Director | 08-Apr-2021 | Current |
Param Tripathi  | Director | 19-Oct-2023 | Current |
| Jeehye You | Director | 08-Apr-2021 | Current |
Financial Performance of Megagen Implant India.
Megagen Implant India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.59% increase. The company also saw a substantial fall in profitability, with a 2653.27% decrease in profit. The company's net worth Soared by an impressive increase of 198.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Megagen Implant India?
In 2023, Megagen Implant India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dowwells India Private LimitedActive 2 years 2 monthsParam Tripathi and Jeehye You are mutual person
- Buddtree Advisory Services Private LimitedActive 7 years 7 months
Param Tripathi and Jeehye You are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Megagen Implant India?
Megagen Implant India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Megagen Implant India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megagen Implant India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
